Trial intelligence / Profile preview

SECURE: Cilostazol and Probucol for Plaque Stabilization

NCT01031667Phase 4Completed

Sponsor
Yonsei University
Start
Nov 2009
Primary completion
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of probucol in coronary artery disease (CAD), sponsored by Yonsei University. Started Nov 2009; status: completed.

02

Drugs

probucol
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01031667.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01031667.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call